Arlington, Virginia - Alessandro Doria, MD, PhD, MPH, has been selected to receive the American Diabetes Association’s® (ADA’s) 2018 Edwin Bierman Award. This award recognizes a leading scientist who has made outstanding contributions in the field of diabetes-related macrovascular complications and related risk factors. Dr. Doria will be recognized with this honor during the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando. Dr. Doria will deliver the Edwin Bierman Award Lecture, titled “Leveraging Genetics to Improve Cardiovascular Health in Diabetes,” on Monday, June 25.

Currently an Associate Professor of Medicine at Harvard Medical School, as well as Senior Investigator in the Section on Genetics and Epidemiology and Co-Director of the Molecular Phenotyping and Genotyping Core at the Joslin Diabetes Center, Dr. Doria is a world-renowned expert in the genetic epidemiology of coronary heart disease in diabetes.

With more than 100 original publications, Dr. Doria’s research has paved the way for innovative diagnostic and therapeutic approaches. The overarching concept of his research has been that the risk of coronary heart disease in people with diabetes is determined by a synergism between exposure to the diabetic environment and permissive genetic factors. He has persistently worked to identify these genetic factors and turn this knowledge into novel approaches to prevent, stop or reverse the macrovascular complications of diabetes. 

“I would like to congratulate Dr. Doria on this achievement, and thank him for his contributions to our understanding of vascular complications of diabetes,” said the ADA’s 2018 President of Medicine and Science Jane E.B. Reusch, MD. “His tremendous body of work has made a lasting impact in the sphere of diabetes and its associated complications.”

Dr. Doria also serves as Associate Editor of the ADA’s journal Diabetes and is a dedicated mentor to young researchers in the fields of epidemiology, genetics and macrovascular complications.

The American Diabetes Association’s 78th Scientific Sessions, to be held June 22-26, 2018, at the Orange County Convention Center in Orlando, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, more than 16,000 health care professionals from around the world will have exclusive access to more than 3,000 original diabetes research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight theme areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Felicia Hill-Briggs, PhD, ABPP, President of Health Care and Education, will deliver her address, “The American Diabetes Association in the Era of Health Care Transformation,” on Saturday, June 23, and Jane E.B. Reusch, MD, President of Medicine and Science, will present her address, “24/7/365 – Lifetime with Diabetes,” on Sunday, June 24. In total, the 2018 Scientific Sessions includes 375 oral presentations; 2,117 poster presentations, including 47 moderated poster discussions; and 297 published-only abstracts. Join the Scientific Sessions conversation on social media using #2018ADA.